Further, in PAH-PASMCs, the direct upstream activator of CHK-1, phospho-ATK [74,75], was upregulated, and mir-424, which targets CHK-1 [76], was also found to be downregulated. The gene discussed is CHEK1; the disease is pulmonary arterial hypertension.